Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,713 | 331 | 57.5% |
| Education | $3,146 | 7 | 26.9% |
| Travel and Lodging | $1,808 | 17 | 15.5% |
| Gift | $13.57 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $5,349 | 28 | $0 (2023) |
| ABBVIE INC. | $658.99 | 49 | $0 (2023) |
| Novo Nordisk Inc | $537.99 | 29 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $516.24 | 24 | $0 (2023) |
| Avanos Medical | $379.74 | 8 | $0 (2023) |
| Merck Sharp & Dohme LLC | $377.55 | 18 | $0 (2024) |
| PFIZER INC. | $367.34 | 24 | $0 (2024) |
| Exeltis, USA Inc. | $353.09 | 22 | $0 (2024) |
| Astellas Pharma US Inc | $287.37 | 13 | $0 (2024) |
| Amgen Inc. | $257.74 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $746.59 | 41 | Biogen, Inc. ($192.17) |
| 2023 | $964.92 | 45 | Astellas Pharma US Inc ($101.41) |
| 2022 | $1,923 | 52 | Intuitive Surgical, Inc. ($852.05) |
| 2021 | $771.85 | 57 | AbbVie Inc. ($225.59) |
| 2020 | $597.89 | 35 | Lupin Inc. ($85.37) |
| 2019 | $740.44 | 37 | Intuitive Surgical, Inc. ($140.69) |
| 2018 | $5,180 | 56 | Intuitive Surgical, Inc. ($4,179) |
| 2017 | $754.96 | 33 | HOLOGIC INC ($148.66) |
All Payment Transactions
356 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $26.43 | General |
| Category: Neurology | ||||||
| 12/16/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: CONTRACEPTIVE | ||||||
| 12/05/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: Neurology | ||||||
| 12/02/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: WOMENS HEALTH | ||||||
| 12/02/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Biological | ||||||
| 11/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Obesity | ||||||
| 10/27/2024 | MILLICENT US INC | INTRAROSA (Drug), FEMRING | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 10/24/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: WOMENS HEALTH | ||||||
| 10/15/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Neurology | ||||||
| 10/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Obesity | ||||||
| 10/03/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Neurology | ||||||
| 09/18/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 09/16/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: CONTRACEPTIVE | ||||||
| 09/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Biological | ||||||
| 09/04/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: Neurology | ||||||
| 08/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Obesity | ||||||
| 08/22/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: VACCINES | ||||||
| 08/19/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: Neurology | ||||||
| 08/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Biological | ||||||
| 07/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Obesity | ||||||
| 06/26/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), GARDASIL 9 | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: VACCINE | ||||||
| 06/20/2024 | PFIZER INC. | PREMARIN (Drug), MYFEMBREE, NURTEC ODT | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: WOMENS HEALTH | ||||||
| 06/11/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 06/10/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Endocrinology | ||||||
| 06/04/2024 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $23.50 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 163 | 184 | $43,962 | $12,870 |
| 2022 | 7 | 235 | 280 | $64,234 | $18,536 |
| 2021 | 8 | 270 | 315 | $66,435 | $19,865 |
| 2020 | 6 | 210 | 227 | $40,224 | $11,398 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 87 | $19,314 | $4,718 | 24.4% |
| 77067 | Screening mammography | Office | 2023 | 37 | 37 | $11,988 | $4,331 | 36.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 25 | $8,250 | $2,032 | 24.6% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 35 | 35 | $4,410 | $1,790 | 40.6% |
| 77067 | Screening mammography | Office | 2022 | 51 | 51 | $16,524 | $6,232 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 70 | 109 | $24,198 | $5,995 | 24.8% |
| 77063 | Screening 3d breast mammography | Office | 2022 | 46 | 46 | $5,796 | $2,394 | 41.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 24 | 24 | $7,920 | $1,834 | 23.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 14 | 14 | $4,648 | $833.97 | 17.9% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2022 | 15 | 18 | $2,574 | $623.22 | 24.2% |
| 87661 | Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique | Office | 2022 | 15 | 18 | $2,574 | $623.22 | 24.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 81 | 118 | $26,196 | $6,636 | 25.3% |
| 77067 | Screening mammography of both breasts | Office | 2021 | 55 | 55 | $17,820 | $6,409 | 36.0% |
| 77063 | Screening digital tomography of both breasts | Office | 2021 | 48 | 48 | $6,048 | $2,603 | 43.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 19 | $6,270 | $1,505 | 24.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 24 | 24 | $2,808 | $923.76 | 32.9% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2021 | 15 | 17 | $2,431 | $596.53 | 24.5% |
| 87511 | Detection test for gardnerella vaginalis (bacteria), amplified probe technique | Office | 2021 | 15 | 17 | $2,431 | $596.53 | 24.5% |
| 87661 | Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique | Office | 2021 | 15 | 17 | $2,431 | $596.53 | 24.5% |
| 77067 | Mammography of both breasts | Office | 2020 | 28 | 28 | $9,297 | $3,627 | 39.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 53 | 67 | $14,874 | $2,933 | 19.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 61 | 61 | $7,137 | $2,351 | 32.9% |
| 77063 | Screening digital tomography of both breasts | Office | 2020 | 28 | 28 | $3,978 | $1,525 | 38.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 14 | 14 | $4,648 | $861.05 | 18.5% |
| 81002 | Urinalysis, manual test | Office | 2020 | 26 | 29 | $290.00 | $100.22 | 34.6% |
About Dr. Janelle Perrone, M.D
Dr. Janelle Perrone, M.D is a Obstetrics & Gynecology healthcare provider based in College Station, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2012. The National Provider Identifier (NPI) number assigned to this provider is 1982950424.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Janelle Perrone, M.D has received a total of $11,680 in payments from pharmaceutical and medical device companies, with $746.59 received in 2024. These payments were reported across 356 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($6,713).
As a Medicare-enrolled provider, Perrone has provided services to 878 Medicare beneficiaries, totaling 1,006 services with total Medicare billing of $62,670. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location College Station, TX
- Active Since 08/02/2012
- Last Updated 05/24/2024
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1982950424
Products in Payments
- Da Vinci Surgical System (Device) $5,349
- Kyleena (Drug) $438.88
- ON-Q PUMP AND ACCESSORIES (Device) $354.78
- SLYND (Drug) $329.50
- PREMARIN (Drug) $303.15
- Wegovy (Drug) $299.45
- NEXPLANON (Drug) $295.07
- LO LOESTRIN FE (Drug) $220.52
- Saxenda (Drug) $204.28
- EVENITY (Biological) $176.88
- Veozah (Drug) $170.14
- ZURZUVAE (Drug) $144.64
- Orilissa (Drug) $144.10
- GELPOINT V-PATH (Device) $130.00
- NovaSure (Device) $125.69
- Phexxi (Drug) $123.71
- Lupron (Drug) $110.63
- UBRELVY (Drug) $110.54
- ORIAHNN (Drug) $105.36
- Endosee (Device) $98.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in College Station
Cynthia Jansky, Md, MD
Obstetrics & Gynecology — Payments: $3,923
Rhoda Conant, M.d, M.D
Obstetrics & Gynecology — Payments: $3,075
Michele Garant-Smotherman, Do, DO
Obstetrics & Gynecology — Payments: $3,070
Dr. Randy Smith, M.d, M.D
Obstetrics & Gynecology — Payments: $2,376
Dr. Candice Luedke, D.o, D.O
Obstetrics & Gynecology — Payments: $1,979
Lelve Gayle, Md, MD
Obstetrics & Gynecology — Payments: $1,608